Results 31 to 40 of about 126,590 (205)

Prospects of Using Domestic Hepatitis B Vaccines to Ensure Sanitary and Epidemiological Well-Being

Эпидемиология и вакцинопрофилактика, 2017
On the basis of the literature review and own authors' researches, the results of assessment of safety and immunogenicity of native immunobiological medicinal preparations (hepatitis B vaccines «Combiotex», the combined vaccines Bubo-M and Bubo-Kok) in ...
I. V. Fel'dblyum
doaj   +1 more source

Investigation the longevity of hepatitis B surface antibody in vaccinated students of Hormozgan university of medical sciences

Iranian Journal of Microbiology, 2023
Background and Objectives: Hepatitis B is a common chronic viral infection in humans. Universal use of hepatitis B vaccine is crucial for controlling the infection, but the duration of vaccine-induced immunity remains uncertain.
Majid Najafi-Asl, Soghra Abdi, Mehdi Hassani Azad, Marzieh Norouzian   +3 more
doaj   +1 more source

Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems [PDF]

, 2014
Cervical cancer is the second-most-common cause of malignancies in women worldwide, and the oncogenic activity of the human papilloma virus types (HPV) E7 protein has a crucial role in anogenital tumors.
Atyabi, F., Ghaemi, A., Gorji, A., Kalhor, H.R., Kelishadi, M., Moradi, A., Sajadian, A., Tabarraei, A., Tahamtan, A.   +8 more
core   +3 more sources

Immunotherapy for Chronic Hepatitis B Virus Infection

Gut and Liver, 2018
While new therapies for chronic hepatitis C virus infection have delivered remarkable cure rates, curative therapies for chronic hepatitis B virus (HBV) infection remain a distant goal.
Antonio Bertoletti, Nina Le Bert
doaj   +1 more source

Research progress of therapeutic vaccines for treating chronic hepatitis B

Human Vaccines & Immunotherapeutics, 2017
Hepatitis B virus (HBV) is a member of Hepadnavirus family, which leads to chronic infection in around 5% of patients with a high risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma.
Jianqiang Li, Mengru Bao, Jun Ge, Sulin Ren, Tong Zhou, Fengchun Qi, Xiuying Pu, Jia Dou   +7 more
doaj   +1 more source

Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review

Vaccines
Background: Co-administration of vaccines can impact the immune response and safety. We aim to systematically review the current scientific literature and find evidence regarding the immunogenicity and safety of pneumococcal vaccines co-administered with
Raziyeh Niyati, Omid Rezahosseini, Christina Ekenberg, Carsten Schade Larsen, Zitta Barrella Harboe   +4 more
doaj   +1 more source

Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review

Viruses, 2023
Vaccination has been confirmed to be the safest and, sometimes, the only tool of defense against threats from infectious diseases. The successful history of vaccination is evident in the control of serious viral infections, such as smallpox and polio ...
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly   +7 more
doaj   +1 more source

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium [PDF]

, 2019
Funding text The authors are grateful for the vital contributions of the participating study volunteers, clinicians, nurses, and laboratory technicians at the Surrey study site.
Bodinham, C., Bottazzi, B., DelGiudice, G., Denoel, P., Greenwood, A., Jonsdottir, I., Kaufmann, S., Kester, K., Leroux-Roels, G., Lewis, D., Linley, C., Maertzdorf, J., Mantovani, A., Mollenkopf, H., Pizzoferro, K., van den Berg, R., Weiner, J.   +16 more
core   +1 more source

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review

Human Vaccines & Immunotherapeutics
Hepatitis B vaccination is the most effective means of interrupting HBV transmission. Although the hepatitis B vaccine is very effective and safe, adverse events following immunization do occur and need to be reported so that problems can be identified ...
Xiaoying Gong, Quanjun Fang, Jianyue Zhong, Canjie Zheng, Zhiying Yin   +4 more
doaj   +1 more source

Het Rijksvaccinatieprogramma in Nederland. Ontwikkelingen in 2006 [PDF]

, 2007
In 2006 several changes were made in the Dutch National Immunisation Programme (NIP): Hepatitis B vaccination at birth was added for children born to mothers positive for hepatitis B surface antigen; a new vaccine for diphtheria, tetanus, pertussis (a ...
Abbink F, Avoort HGAM van der, Berbers WAM, Binnendijk RS van, Boot HJ, Duynhoven YTHP van, Geraedts JLE, Gerritsen AAM, Greeff SC de, Hahne SJM, Hofhuis A, Kemmeren JM, Kimman TG, Klein MR, Koedijk FDH, Koopmans MPG, Kremer K, Maas NAT van der, Mangen MJJ, Meijer A, Mooi FR, Mylius SD, Notermans DW, Op de Coul ELM, Sande MAB van der, Schouls LM, Soolingen D van, Steenbergen JE van, Vermeer-de Bondt PE, Wallinga J, Wit GA de   +30 more
core